» Human Factor VII congenital deficient plasma (severe

HEMOSTASIS COAGULATION RESEARCH DEFICIENT PLASMAS CONGENITAL DEFICIENT PLASMAS (BOTTLES)

Human Factor VII congenital deficient plasma (severe <1%)

Plasma from a human donor with congenital FVII deficiency.

Packaging in bottle. The minimum packaged volume is 50 mL. The price offer is based on the volume requested.

Reference	6-PPD07C-S
Presentation	Vial
Format	Minimum 50 mL
Quote

Price list, safety data sheets and notices are accessible to our registered customers.

Reference	Presentation	Format	Quote	Product sheet
6-PPD07C-S	Vial	Minimum 50 mL

Price list, safety data sheets and notices are accessible to our registered customers.

Factor VII (FVII) is a glycoprotein synthesized by the liver, zymogen of a serine protease. It is a vitamin K dependent factor belonging to the prothrombin complex. Its half-life is 4 to 6 hours and it is the only coagulation factor present in trace amounts in its active form.
When tissue factor appears on the endothelial surface, activated FVII associates with it initiating the extrinsic pathway for coagulation.
This complex (FT-FVIIa) will activate the FX in FXa and the FIX in FIXa.

Special plasmas are derived from patients with a congenital deficiency, severe or moderate, or presenting a particular profile. No buffer or preservatives are added.
Quickly frozen at -80° C, the plasma maintains perfectly intact the matrix.
All plasmas are stable when stored at -40° C to -80° C.
We carefully pack with dry ice during shipment.
No additive or preservative.
Expiry date > 1 year. Plastic vials.

Minimize test time.
Ready to use.

	These kits are manufactured in accordance with the 98/79 EC directive for in vitro diagnostic devices. Only CE marked products can be used for diagnostic applications in Europe.
	These kits are intended for in vitro diagnostic use.
	These kits are for research use only and are not intended to be used for diagnostic procedures.
	Federal Drug Administration, FDA validates diagnostic kits for in vitro diagnostic use in the United States.
	Biological risk products.
	Storage between 2 and 8 ° C.
	Reactive in liquid form.
	Reactive in lyophilized form.
	Reactive in frozen form.
	Stability after opening at 2-8 ° C.
	Products that can be refrozen.
	Stability 12 months after refreezing at -20 ° C.
	Manufacturer.
	Importer
	Distributor.

HEMOSTASIS COAGULATION RESEARCH DEFICIENT PLASMAS CONGENITAL DEFICIENT PLASMAS (BOTTLES)